XML 101 R80.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Information - Schedule of Segment Data (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue $ 9,883,000 $ 7,653,000 $ 18,315,000 $ 10,657,000  
Share of loss from investments in equity accounted investees 794,000 741,000 1,966,000 939,000  
Interest income 3,817,000   11,575,000    
Interest expense (83,000)   (90,000)    
Interest income, net 3,734,000 9,442,000 11,485,000 11,528,000  
Impairment loss on goodwill and intangible assets 40,000,000 0 40,000,000 0  
Depreciation and amortization 684,000 408,000 1,371,000 726,000  
Income tax expense 0 0 0 0  
Net (loss) income (107,703,000) 185,888,000 (32,022,000) 499,876,000  
Consolidated balance sheets          
Total assets 1,910,287,000   1,910,287,000   $ 2,090,442,000
Investments in equity accounted investees 933,000   933,000   557,000
Goodwill 179,736,000   179,736,000   $ 214,794,000
Purchase of property, plant and equipment, net     13,344,000    
Operating Segments | United States          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 2,174,000   4,350,000    
Share of loss from investments in equity accounted investees 0   0    
Interest income 8,000   13,000    
Interest expense 0   0    
Interest income, net 8,000   13,000    
Impairment loss on goodwill and intangible assets 40,000,000   40,000,000    
Depreciation and amortization 36,000   69,000    
Income tax expense 0   0    
Net (loss) income (47,762,000)   (57,567,000)    
Consolidated balance sheets          
Total assets 250,470,000   250,470,000    
Investments in equity accounted investees 0   0    
Goodwill 178,414,000   178,414,000    
Purchase of property, plant and equipment, net     219,000    
Operating Segments | Rest of World          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 7,709,000   13,965,000    
Share of loss from investments in equity accounted investees 794,000   1,966,000    
Interest income 3,811,000   11,562,000    
Interest expense (83,000)   (90,000)    
Interest income, net 3,728,000   11,472,000    
Impairment loss on goodwill and intangible assets 0   0    
Depreciation and amortization 654,000   1,302,000    
Income tax expense 0   0    
Net (loss) income (52,899,000)   39,257,000    
Consolidated balance sheets          
Total assets 348,569,000   348,569,000    
Investments in equity accounted investees 933,000   933,000    
Goodwill 1,322,000   1,322,000    
Purchase of property, plant and equipment, net     13,125,000    
Corporate          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 0   0    
Share of loss from investments in equity accounted investees 0   0    
Interest income (2,000)   0    
Interest expense 0   0    
Interest income, net (2,000)   0    
Impairment loss on goodwill and intangible assets 0   0    
Depreciation and amortization (6,000)   0    
Income tax expense 0   0    
Net (loss) income (7,042,000)   (13,712,000)    
Consolidated balance sheets          
Total assets 1,311,248,000   1,311,248,000    
Investments in equity accounted investees 0   0    
Goodwill 0   0    
Purchase of property, plant and equipment, net     0    
Cannabis flower          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 5,674,000 6,096,000 8,415,000 7,921,000  
Cannabis flower | Operating Segments | United States          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 0   0    
Cannabis flower | Operating Segments | Rest of World          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 5,674,000   8,415,000    
Cannabis flower | Corporate          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 0   0    
Cannabis extracts          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 4,091,000 1,535,000 9,667,000 2,638,000  
Cannabis extracts | Operating Segments | United States          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 2,174,000   4,350,000    
Cannabis extracts | Operating Segments | Rest of World          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 1,917,000   5,317,000    
Cannabis extracts | Corporate          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 0   0    
Other          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 118,000 $ 22,000 233,000 $ 98,000  
Other | Operating Segments | United States          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 0   0    
Other | Operating Segments | Rest of World          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 118,000   233,000    
Other | Corporate          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue $ 0   $ 0